All the news Showing 10 of 10 articles from: Diabetes & HCVGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis C treatment reduces stroke and heart attack risk Keith Alcorn / 18 February 2021 Hepatitis C treatment reduces the risk of subsequent stroke or heart attack by between 25 and 35%, a meta-analysis of studies published in the Journal of Viral Hepatitis shows. People with hepatitis C ... Hepatitis C treatment reduces risk of diabetes Liz Highleyman / 18 March 2019 Treatment of hepatitis C virus (HCV) infection is associated with better glucose control and a lower likelihood of developing diabetes, according to a report at the Conference on Retroviruses and Opportunistic Infections (CROI ... Curing Hepatitis C Is Tied to Improved Diabetes Markers Hep / 20 December 2018 Successful HCV therapy reduces the risk of diabetes Michael Carter / 22 March 2018 Successful hepatitis C virus (HCV) therapy reduces the risk of developing type 2 diabetes by approximately a fifth, according to results of a large US study published in the Journal ... Managing the Fruits of HCV Cure: How Much Care do the Cured Need? Healio / 22 January 2018 Curing hepatitis C reduces the risk of diabetes & kidney failure in people with HIV/HCV co-infection Keith Alcorn / 01 February 2017 Curing hepatitis C infection substantially reduces the risk of developing type 2 diabetes in people with HIV/hepatitis C virus (HCV) co-infection, but does not reduce the risk of cardiovascular disease, ... Diabetes is a risk factor for the development of liver cancer for people with cirrhosis successfully treated for HCV Michael Carter / 04 July 2016 Diabetes is a strong risk factor for hepatocellular carcinoma (HCC) in people with hepatitis C virus (HCV) infection who have received successful treatment for the infection, Swedish investigators report in Clinical Infectious Diseases. ... Cardiovascular disease risk is higher for people with hepatitis C Keith Alcorn / 20 January 2016 People with hepatitis C are at higher risk of dying from cardiovascular disease, suffering a stroke or developing cardiovascular problems than people with similar risk factors for heart disease who ... Antivirals for HCV improve kidney and cardiovascular diseases in diabetic patients Eurekalert Medicine & Health / 11 December 2013 Interferon-free therapy alters lipid metabolism, glucose homeostasis in chronic HCV patients Healio Hepatology / 14 October 2013 ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds